Paper995158
Effect of insulin and glucagon on fulminant murine hepatitis.
Farivar M and 3 others. N Engl J Med, 1976. Cited by 94 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Effect of insulin and glucagon on fulminant murine hepatitis. Papers, record 995158. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/995158
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glucagon | Major topic |
| Hepatitis A | Major topic |
| Insulin | Major topic |
| Liver Regeneration | Major topic |
| Acute Disease | |
| Animals | |
| Disease Models, Animal | |
| Drug Synergism | |
| Female | |
| Mice | |
| Time Factors |
Source PubMed
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 94 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34,966,588 | Preclinical models of acute liver failure: a comprehensive review. | PeerJ | 2021 | https://conductscience.org/library/papers/34966588 | PubMed |
| 31,191,707 | Metabolic and Epigenetic Action Mechanisms of Antidiabetic Medicinal Plants. | Evid Based Complement Alternat Med | 2019 | https://conductscience.org/library/papers/31191707 | PubMed |
| 16,382,351 | Acute liver failure: a critical appraisal of available animal models. | Metab Brain Dis | 2005 | https://conductscience.org/library/papers/16382351 | PubMed |
| 9,213,259 | Prolonged intrahepatic cholestasis in acute-onset, severe autoimmune hepatitis. | J Gastroenterol | 1997 | https://conductscience.org/library/papers/9213259 | PubMed |
| 8,444,417 | Administration of hepatic stimulatory substance alone or with other liver growth factors does not ameliorate acetaminophen-induced liver failure. | Hepatology | 1993 | https://conductscience.org/library/papers/8444417 | PubMed |
| 8,391,447 | Glycogen storage disease I and hepatocellular tumours. | Eur J Pediatr | 1993 | https://conductscience.org/library/papers/8391447 | PubMed |
| 7,429,306 | Evidence for liver cell proliferation during fatal acute liver failure. | Gut | 1980 | https://conductscience.org/library/papers/7429306 | PubMed |
| 6,433,587 | Acute hepatic failure in children. | Yale J Biol Med | 1984 | https://conductscience.org/library/papers/6433587 | PubMed |
| 6,402,285 | Carbon tetrachloride poisoning treated with hemodialysis and total parenteral nutrition. | Can Med Assoc J | 1983 | https://conductscience.org/library/papers/6402285 | PubMed |
| 3,539,743 | The effect of hepatic stimulatory substance, isolated from regenerating hepatic cytosol, and 50,000 and 300,000 subfractions in enhancing survival in experimental acute hepatic failure in rats treated with D-galactosamine. | Hepatology | 1986 | https://conductscience.org/library/papers/3539743 | PubMed |
| 3,315,819 | Clinical evaluation of glucagon and insulin in therapy of fulminant hepatitis. | Gastroenterol Jpn | 1987 | https://conductscience.org/library/papers/3315819 | PubMed |
| 2,715,130 | Stimulating effects of bovine small intestine mucosal factors on rat hepatocyte development. | In Vitro Cell Dev Biol | 1989 | https://conductscience.org/library/papers/2715130 | PubMed |
| 2,663,609 | A multi-centre double-blind controlled trial of glucagon and insulin therapy for severe acute hepatitis. | Gastroenterol Jpn | 1989 | https://conductscience.org/library/papers/2663609 | PubMed |
| 2,472,994 | Reciprocal changes in serum albumin and alpha-fetoprotein levels in the recovery course of acute viral hepatitis stimulated by glucagon and insulin therapy: analysis of a double blind controlled trial. | Gastroenterol Jpn | 1989 | https://conductscience.org/library/papers/2472994 | PubMed |
| 2,298,913 | Effect of ethanol on polyamine synthesis during liver regeneration in rats. | J Clin Invest | 1990 | https://conductscience.org/library/papers/2298913 | PubMed |
| 2,032,521 | Insulin and glucagon therapy of acute hepatic failure. | Dig Dis Sci | 1991 | https://conductscience.org/library/papers/2032521 | PubMed |
| 2,032,519 | Animal models of fulminant hepatic failure. | Dig Dis Sci | 1991 | https://conductscience.org/library/papers/2032519 | PubMed |
| 1,836,544 | In vivo modification of hepatopathy in rat by intestine epithelial HGF. | Naturwissenschaften | 1991 | https://conductscience.org/library/papers/1836544 | PubMed |
| 1,709,604 | Insulin and glucagon levels in fulminant hepatic failure in man. | Dig Dis Sci | 1991 | https://conductscience.org/library/papers/1709604 | PubMed |
| 1,702,048 | Treatment of fulminant hepatic failure with insulin and glucagon. A randomized, controlled trial. | Dig Dis Sci | 1991 | https://conductscience.org/library/papers/1702048 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/995158
GET https://conductscience.org/api/papers/v1/995158/cited_by?page=2